916483-67-5 Usage
Description
[(3S)-4-benzylmorpholin-3-yl]methanol hydrochloride, with the molecular formula C12H18ClNO2, is a hydrochloride salt of 4-benzylmorpholine. It is a heterocyclic amine that features a morpholine ring with a benzyl group attached. This white crystalline powder is soluble in water and ethanol, and it is widely utilized in the pharmaceutical industry for the synthesis of various pharmaceuticals and organic molecules.
Uses
Used in Pharmaceutical Industry:
[(3S)-4-benzylmorpholin-3-yl]methanol hydrochloride is used as a key intermediate in the synthesis of various drugs and organic compounds. Its unique chemical structure allows it to serve as a building block for the development of new pharmaceuticals, contributing to the advancement of medical treatments.
Used in Organic Chemistry:
In the field of organic chemistry, [(3S)-4-benzylmorpholin-3-yl]methanol hydrochloride is employed as a versatile reagent for the synthesis of a range of organic molecules. Its ability to form meta-depside bonds and interact with biopolymers and macromolecules makes it a valuable compound for creating complex organic structures.
Used in Drug Synthesis:
[(3S)-4-benzylmorpholin-3-yl]methanol hydrochloride is used as a crucial component in the production of drugs, particularly those targeting specific medical conditions. Its role in drug synthesis is essential for the development of novel therapeutic agents with improved efficacy and reduced side effects.
Check Digit Verification of cas no
The CAS Registry Mumber 916483-67-5 includes 9 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 6 digits, 9,1,6,4,8 and 3 respectively; the second part has 2 digits, 6 and 7 respectively.
Calculate Digit Verification of CAS Registry Number 916483-67:
(8*9)+(7*1)+(6*6)+(5*4)+(4*8)+(3*3)+(2*6)+(1*7)=195
195 % 10 = 5
So 916483-67-5 is a valid CAS Registry Number.
916483-67-5Relevant articles and documents
ANHYDRATE FORMS OF A PYRIDINE DERIVATIVE
-
Page/Page column 20-21, (2011/04/14)
The invention relates to the compound of formula (I) in a crystalline anhydrate form, pharmaceutical formulations containing them, their use in therapy and processes for preparing the same.
